Pet Cancer Therapeutics Market worth over $300 million by 2024: Global Market Insights, Inc.
August 09, 2017 06:30 ET
|
Global Market Insights, Inc
Ocean View, Delaware, Aug. 09, 2017 (GLOBE NEWSWIRE) -- The Industry Analysis report “Pet Cancer Therapeutics Market By Medicine Type (Chemotherapy Drugs and Vaccines), By Species (Dogs and Cats),...
Cellular Biomedicine Group (CBMG) Announces the Addition of a Second Clinical Site in the Expansion of its Chimeric Antigen Receptor T-cell (CAR-T) Phase I Clinical Trial for Its CARD-1 Trial in Patients with Non-Hodgkin Lymphoma (NHL)
May 15, 2017 06:22 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., May 15, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CARD-1) for C-CAR011 in Patients with Refractory Diffuse Large B-cell Lymphoma (DLBCL) in China
November 29, 2016 07:16 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in the...
From Nurse to Patient
February 06, 2014 17:44 ET
|
Genentech
MISSION, KS--(Marketwired - Feb 6, 2014) - (Family Features) Despite her career as a scrub nurse for general cancer surgeries, a personal diagnosis of cancer still came as a surprise.
"It...
MMRGlobal Receives Cancer-Fighting Anti-CD20 Monoclonal Antibodies Patent in Korea
January 31, 2014 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Jan 31, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Adds Japan & South Korea to China in Filing of Cancer Fighting Patent Under Expedited Patent Allowance Program
August 26, 2013 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Aug 26, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
Lack of Information Biggest Barrier for Lymphoma Patients
December 21, 2012 15:54 ET
|
Lymphoma Coalition
Mississauga, Ontario, Dec. 21, 2012 (GLOBE NEWSWIRE) -- Lack of basic, but crucial, information acts as a barrier to the
proper diagnosis and treatment of lymphoma patients worldwide. This
contributes...
MMRGlobal to File Anti-CD20 Antibody and B-Cell Vaccine Patents Targeting Cancers
July 27, 2012 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwire - Jul 27, 2012) - MMRGlobal, Inc. (www.mmrglobal.com) (OTCBB: MMRF) ("MMR") today announced that it is filing two additional divisional patent applications that are...
Semafore Pharmaceuticals Announces Presentation Highlighting Activity of Multi-Kinase, PI3K/mTOR Inhibitor SF1126 at 2011 AACR Annual Meeting
March 09, 2011 07:30 ET
|
Semafore Pharmaceuticals
INDIANAPOLIS, March 9, 2011 (GLOBE NEWSWIRE) -- Semafore Pharmaceuticals announced today that preclinical data in B-cell malignancies for the company's lead product candidate SF1126 will be presented...
MMRGlobal Settles With Lymphoma Research Foundation
November 30, 2010 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwire - November 30, 2010) - MMRGlobal, Inc. (OTCBB: MMRF) (MMR) today announced it has signed a settlement agreement with the Lymphoma Research Foundation (LRF), resolving its...